Smoking Cessation
Conditions
Brief summary
The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education (HE) comparison intervention, in which both groups also receive standard behavioral smoking cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking outcomes at 1-, 3-, and 6-month follow-ups.
Interventions
Sponsors
National Institute on Drug Abuse (NIDA)
Rhode Island Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
female * at least 18 years of age * smoke 5 or more cigarettes per day * daily smoker for at least the past year * report motivation to quit smoking in the next month of at least 5 on a 10 point scale * report concern of at least 50 on at least one of two 100 point scales assessing weight concern * able to travel to study location for study appointments
Exclusion criteria
* current use of other smoking cessation or weight loss therapies * current use of other tobacco products at least weekly * diagnosis or treatment for non-nicotine substance use disorder with substance use during the past 6 months * lifetime diagnosis or treatment of eating disorder, bipolar disorder, schizophrenia, or schizoaffective disorder * score above established cut-offs on self-report screening measures of depressive symptomology, eating disorder symptomology, alcohol use disorder, or drug use disorder * current suicidality or homicidality * medical condition that is a contraindication for the use of transdermal nicotine patch * lives at same address as current or past participant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Point prevalence abstinence from smoking: percentage of participants in each treatment group who report abstinence from smoking for the 7 days prior to each follow-up assessment | 6 months post-quit date | The investigators will compare the percentage of participants in each treatment group who report abstinence from smoking for the 7 days prior to each follow-up assessment (1-, 3-, and 6-months post-quit date). |
Countries
United States
Outcome results
None listed